Ibere Pharmaceuticals
SEC CIK 1835205 · IBERU · last insider filing 2021-03-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Vollmer Louis J. | Director | filed 2021 - 2021 |
| Imasogie Osagie O | Director · Chief Executive Officer | filed 2021 - 2021 |
| Jones Elaine V | Director | filed 2021 - 2021 |
| Johnson Calvin B. | Director | filed 2021 - 2021 |
| Kerekes Zoltan | Director · Chief Operating Officer | filed 2021 - 2021 |
| Gray Lisa M. | Director · Chief Financial Officer | filed 2021 - 2021 |
| Ukwu Henrietta | Director | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.